Researchers at Purdue University have developed a new type of cancer therapy that uses a modified microRNA, miR-34a, to block cancer cell division. In preclinical tests in mice, treatment using the ...
A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported Monday (Sept. 4 ...
WEST LAFAYETTE — A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As ...
COLUMBUS, Ohio, April 02, 2026--(BUSINESS WIRE)--Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced the ...
A new therapy for cancer uses microRNA to slow or stop division of cancer cells. (Photo provided by Second Bay Studios) WEST LAFAYETTE, Ind. – A new cancer therapy developed by Purdue University ...
Research published in Molecular Therapy Nucleic Acids demonstrates broad biodistribution and controlled PMP22 silencing, supporting advancement toward human trials Armatus Bio, a late-preclinical ...
A new cancer therapy attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. A new cancer therapy developed by Purdue University researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results